RGCVSTENX• 3 Months (Normalized)
RGC vs TENX (Regencell Bioscience Holdings Limited vs Tenax Therapeutics Inc.)
Showing Closing Date Range from Jun, 18 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
RGC Performance $5.68
-52.71%
Regencell Bioscience Holdings Limited
Normalized Baseline0.00%
TENX Performance $1.82
-84.83%
Tenax Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin RGC LEADS
+32.12%
RGC outperforming by 32.12%
RGCTENX
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
RGC TENX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | RGC Price | RGC Gain (%) | TENX Price | TENX Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $5.68 | -52.71% | $1.82 | -84.83% | +32.12% |
| Sep 15, 2026 | $5.60 | -53.37% | $1.83 | -84.75% | +31.38% |
| Sep 14, 2026 | $5.74 | -52.21% | $1.86 | -84.50% | +32.29% |
| Sep 11, 2026 | $5.64 | -53.04% | $1.86 | -84.50% | +31.46% |
| Sep 10, 2026 | $5.64 | -53.08% | $1.95 | -83.75% | +30.67% |
| Sep 09, 2026 | $5.85 | -51.29% | $2.13 | -82.25% | +30.96% |
| Sep 08, 2026 | $6.82 | -43.21% | $1.98 | -83.50% | +40.29% |
| Sep 04, 2026 | $6.89 | -42.63% | $1.94 | -83.83% | +41.20% |
| Sep 03, 2026 | $6.48 | -46.04% | $1.78 | -85.17% | +39.13% |
| Sep 02, 2026 | $6.31 | -47.46% | $1.85 | -84.58% | +37.12% |
| Sep 01, 2026 | $5.50 | -54.20% | $1.80 | -85.00% | +30.80% |
| Aug 31, 2026 | $5.51 | -54.12% | $1.84 | -84.67% | +30.55% |
| Aug 28, 2026 | $5.50 | -54.20% | $2.13 | -82.25% | +28.05% |
| Aug 27, 2026 | $5.52 | -54.04% | $2.19 | -81.75% | +27.71% |
| Aug 26, 2026 | $5.50 | -54.20% | $2.12 | -82.33% | +28.13% |
Page 1 of 5